Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut ... is being designed to beef up local end-to-end insulin production and bolster the drugmaker’s production ...

We've not often seen big discounts on the gorgeously designed Molekule Air Mini+ so this one had us breathing heavily in that newly-purified air. When you purchase through links on our site, we ...

Pulmonary administration of insulin (inhaled insulin) results in rapidly discernible plasma insulin levels and glucose-lowering effect, albeit with a bioavailability that is 10-26% that of ...

BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a significant boost in the market against Pfizer’s tafamidis and potentially ...

But that's not discouraging Pfizer. After pledging to invest more $1 billion in the country and strengthen ties to local biotechs earlier this month, the New York pharma giant is lining up another ...

Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer while it works to fend off activist criticism that its pipeline is underwhelming. Boshoff ...

Pfizer PFE-1.33%decrease; red down pointing triangle elevated the executive in charge of its cancer-drugs business to oversee all of the drugmaker’s research and development, a crucial move at a ...

Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own Chris Boshoff, M.D., Ph.D., for the job and prompting a domino ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD ...